APM | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 0%

Liquidity 0%

Performance 10%

Performance

5 Days

17.90%

1 Month

29.05%

3 Months

-53.87%

6 Months

-81.87%

1 Year

-62.88%

2 Year

-86.69%

Key data

Stock price

$0.86

P/E Ratio

0.00

DAY RANGE

$0.86 - $0.90

EPS

$0.00

52 WEEK RANGE

$0.71 - $17.49

52 WEEK CHANGE

-$65.27

MARKET CAP

8.784 M

YIELD

N/A

SHARES OUTSTANDING

2.938 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

AVERAGE 10 VOLUME

$21,607

AVERAGE 30 VOLUME

$46,905

Company detail

CEO: Darren Lui
Region: US
Website: www.aptorumgroup.com
Employees: 30
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Aptorum Group Limited engages in the discovery, development, and commercialization of therapeutic products. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas.

APM - Aptorum Group Ltd